We detected the phosphorylation levels of Chk1 on these three active sites and found that with DNA damage, Chk1 was activated in AD human brains, APP/PS1 mouse hippocampus, and Aβ-treated primary neurons. This evidence concerns the gene CHEK1 and Alzheimer disease.